This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Teva Pharmaceutical Industries Ltd (TEVA)

NYSE: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 1.04B 2.88B 1.10B 1.25B
Receivables 5.34B 5.57B 6.21B 5.48B
Inventories 5.05B 5.50B 5.01B 3.87B
Other Current Assets 1.21B 1.26B 0.00 0.00
Total Current Assets 13.72B 16.36B 14.45B 12.04B
Property, Plant & Equipment, Gross 9.74B 9.14B 8.38B 6.62B
Accumulated Depreciation & Depletion 3.10B 2.82B 2.43B 2.26B
Property, Plant & Equipment, Net 6.64B 6.32B 5.95B 4.36B
Intangibles 6.48B 7.74B 10.32B 5.75B
Other Non-Current Assets 1.70B 1.34B 991.00M 632.00M
Total Non-Current Assets 33.79B 34.25B 35.69B 26.11B
Liabilities & Shareholder Equity
Total Assets 47.51B 50.61B 50.14B 38.15B
Accounts Payable 3.32B 3.38B 3.74B 2.52B
Short Term Debt 1.80B 3.01B 3.75B 1.43B
Other Current Liabilities 6.84B 6.51B 5.82B 4.40B
Total Current Liabilities 11.96B 12.89B 13.85B 9.69B
Long Term Debt 10.39B 11.71B 10.24B 4.11B
Deferred Income Taxes 1.25B 1.85B 2.61B 1.35B
Other Non-Current Liabilities 1.27B 1.29B 1.11B 998.00M
Minority Interest -16.00M -53.00M 9.00M 8.00M
Total Non-Current Liabilities 12.98B 14.95B 14.10B 6.51B
Total Liabilities 24.94B 27.84B 27.95B 16.20B
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 22.56B 22.77B 22.20B 21.95B
Common Par 50.00M 50.00M 50.00M 49.00M
Additional Paid In Capital 13.63B 13.47B 13.37B 13.25B
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 12.54B 12.35B 11.28B 9.32B
Treasury Stock -3.56B -3.08B -1.92B -1.02B
Other Equity Adjustments -91.00M -17.00M -589.00M 350.00M
Total Capitalization 32.95B 34.48B 32.43B 26.06B
Total Equity 22.56B 22.77B 22.20B 21.95B
Total Liabilities & Stock Equity 47.51B 50.61B 50.14B 38.15B
Total Common Shares Outstanding 946.87M 856.62M 882.99M 897.50M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 99.00M 87.00M 59.00M 40.00M
Basic Weighted Shares Outstanding 849.00M 872.00M 890.00M 896.00M
Diluted Weighted Shares Outstanding 850.00M 873.00M 893.00M 921.00M
Number of Employees 45000 45948 45754 39660
Number of Part-Time Employees 0 0 0 0
TEVA News

TEVA Teva Pharmaceutical Industries Ltd

Analysts Ratings for TEVA

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 11 10 10 8
Moderate Buy 0 0 0 0
Hold 9 10 10 9
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 1
GET TEVA ANALYST REPORT

Brokerage Partners

TEVA Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs